| Year |
Citation |
Score |
| 2023 |
Bresalier RS, Senore C, Young GP, Allison J, Benamouzig R, Benton S, Bossuyt PMM, Caro L, Carvalho B, Chiu HM, Coupé VMH, de Klaver W, de Klerk CM, Dekker E, Dolwani S, ... ... Ransohoff DF, et al. An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles. Gut. PMID 37463757 DOI: 10.1136/gutjnl-2023-329701 |
0.346 |
|
| 2022 |
Ladabaum U, Church TR, Feng Z, Ransohoff DF, Schoen RE. Counting Advanced Pre-Cancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity. Journal of the National Cancer Institute. PMID 35134969 DOI: 10.1093/jnci/djac027 |
0.316 |
|
| 2021 |
Imperiale TF, Monahan PO, Stump TE, Ransohoff DF. New scoring systems for predicting advanced proximal neoplasia in asymptomatic adults with or without knowing distal colorectal findings: a prospective, cross-sectional study. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). PMID 34545024 DOI: 10.1097/CEJ.0000000000000715 |
0.362 |
|
| 2021 |
Ransohoff DF. Evaluating a New Cancer Screening Blood Test: Unintended Consequences and the Need for Clarity in Policy Making. Journal of the National Cancer Institute. 113: 109-111. PMID 32761203 DOI: 10.1093/jnci/djaa104 |
0.321 |
|
| 2020 |
Imperiale TF, Monahan PO, Stump TE, Ransohoff DF. Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults. Gut. PMID 32994311 DOI: 10.1136/gutjnl-2020-321698 |
0.346 |
|
| 2020 |
Imperiale TF, Itzkowitz SH, Ransohoff DF, Lavin P. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults. Annals of Internal Medicine. 172: 507-508. PMID 32252079 DOI: 10.7326/L20-0113 |
0.373 |
|
| 2020 |
Wieszczy P, Kaminski MF, Franczyk R, Loberg M, Kobiela J, Rupinska M, Kocot B, Rupinski M, Holme O, Wojciechowska U, Didkowska J, Ransohoff D, Bretthauer M, Kalager M, Regula J. Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies. Gastroenterology. 158: 875-883.e5. PMID 31563625 DOI: 10.1053/J.Gastro.2019.09.011 |
0.449 |
|
| 2019 |
Gunter MJ, Alhomoud S, Arnold M, Brenner H, Burn J, Casey G, Chan AT, Cross AJ, Giovannucci E, Hoover R, Houlston R, Jenkins M, Laurent-Puig P, Peters U, Ransohoff D, et al. Meeting Report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30721924 DOI: 10.1093/Annonc/Mdz044 |
0.436 |
|
| 2018 |
Jodal HC, Løberg M, Holme Ø, Adami HO, Bretthauer M, Emilsson L, Ransohoff DF, Hoff G, Kalager M. Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial. Gastroenterology. 155: 1787-1794.e3. PMID 30165051 DOI: 10.1053/j.gastro.2018.08.035 |
0.369 |
|
| 2017 |
Imperiale TF, Ransohoff DF. Screening for Colorectal Neoplasia. The New England Journal of Medicine. 376: 1598-9. PMID 28425279 DOI: 10.1056/NEJMc1702535#SA2 |
0.31 |
|
| 2017 |
Imperiale TF, Yu M, Monahan PO, Stump TE, Tabbey R, Glowinski E, Ransohoff DF. Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment Tool. Journal of the National Cancer Institute. 109. PMID 27582444 DOI: 10.1093/Jnci/Djw181 |
0.312 |
|
| 2016 |
Ransohoff DF, Sox HC. Clinical Practice Guidelines for Colorectal Cancer Screening: New Recommendations and New Challenges. Jama. 315: 2529-31. PMID 27304798 DOI: 10.1001/jama.2016.7990 |
0.392 |
|
| 2015 |
Dunn BK, Steele VE, Fagerstrom RM, Topp CF, Ransohoff D, Cunningham C, Lubet R, Ford LG, Kramer BS. Predictive Value Tools as an Aid in Chemopreventive Agent Development. Journal of the National Cancer Institute. 107. PMID 26420882 DOI: 10.1093/Jnci/Djv259 |
0.342 |
|
| 2015 |
Imperiale TF, Monahan PO, Stump TE, Glowinski EA, Ransohoff DF. Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study. Annals of Internal Medicine. 163: 339-46. PMID 26259154 DOI: 10.7326/M14-1720 |
0.306 |
|
| 2015 |
Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, ... ... Ransohoff DF, et al. Leveraging biospecimen resources for discovery or validation of markers for early cancer detection. Journal of the National Cancer Institute. 107. PMID 25688116 DOI: 10.1093/Jnci/Djv012 |
0.328 |
|
| 2015 |
Dunn BK, Steele VE, Fagerstrom RM, Topp CF, Ransohoff D, Ford LG, Kramer BS. Abstract B53: Predicting efficacy of chemopreventive agents in animal tumor assays by statistical modeling Cancer Prevention Research. 8. DOI: 10.1158/1940-6215.Prev-14-B53 |
0.349 |
|
| 2014 |
Imperiale TF, Ransohoff DF, Itzkowitz SH. Multitarget stool DNA testing for colorectal-cancer screening. The New England Journal of Medicine. 371: 187-8. PMID 25006736 DOI: 10.1056/NEJMc1405215 |
0.333 |
|
| 2014 |
Esserman LJ, Thompson IM, Reid B, Nelson P, Ransohoff DF, Welch HG, Hwang S, Berry DA, Kinzler KW, Black WC, Bissell M, Parnes H, Srivastava S. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. The Lancet. Oncology. 15: e234-42. PMID 24807866 DOI: 10.1016/S1470-2045(13)70598-9 |
0.349 |
|
| 2014 |
Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Multitarget stool DNA testing for colorectal-cancer screening. The New England Journal of Medicine. 370: 1287-97. PMID 24645800 DOI: 10.1056/NEJMoa1311194 |
0.374 |
|
| 2014 |
Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T, Osborn N, Snover D, Day RW, Ransohoff DF. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 63: 317-25. PMID 23408352 DOI: 10.1136/gutjnl-2012-304149 |
0.37 |
|
| 2013 |
Skates SJ, Gillette MA, LaBaer J, Carr SA, Anderson L, Liebler DC, Ransohoff D, Rifai N, Kondratovich M, Težak Ž, Mansfield E, Oberg AL, Wright I, Barnes G, Gail M, et al. Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. Journal of Proteome Research. 12: 5383-94. PMID 24063748 DOI: 10.1021/Pr400132J |
0.365 |
|
| 2013 |
Hayes DF, Allen J, Compton C, Gustavsen G, Leonard DG, McCormack R, Newcomer L, Pothier K, Ransohoff D, Schilsky RL, Sigal E, Taube SE, Tunis SR. Breaking a vicious cycle. Science Translational Medicine. 5: 196cm6. PMID 23903752 DOI: 10.1126/Scitranslmed.3005950 |
0.326 |
|
| 2013 |
Ransohoff DF, Pignone M. Colon cancer screening models: lessons and challenges. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 11: 1167-8. PMID 23660420 DOI: 10.1016/J.Cgh.2013.04.041 |
0.542 |
|
| 2013 |
Ransohoff DF, Pignone M, Sox HC. Development of trustworthy practice guidelines--reply. Jama. 309: 1890-1. PMID 23652517 DOI: 10.1001/Jama.2013.3370 |
0.437 |
|
| 2013 |
Khoury MJ, Janssens AC, Ransohoff DF. How can polygenic inheritance be used in population screening for common diseases? Genetics in Medicine : Official Journal of the American College of Medical Genetics. 15: 437-43. PMID 23412608 DOI: 10.1038/gim.2012.182 |
0.307 |
|
| 2013 |
Ransohoff DF, Pignone M, Sox HC. How to decide whether a clinical practice guideline is trustworthy. Jama. 309: 139-40. PMID 23299601 DOI: 10.1001/Jama.2012.156703 |
0.568 |
|
| 2013 |
Imperiale T, Monahan P, Stump T, Glowinski E, Ransohoff D. Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults is Effectively Stratified by Phenotypic Features: Presidential Poster: 2126 The American Journal of Gastroenterology. 108. DOI: 10.14309/00000434-201310001-02126 |
0.301 |
|
| 2013 |
Dunn BK, Steele VE, Fagerstrom RM, Topp CF, Ransohoff D, Cunningham C, Lubet RA, Ford LG, Kramer BS. Abstract 2595: Predictive value tools as an aid in chemopreventive agent development. Cancer Research. 73: 2595-2595. DOI: 10.1158/1538-7445.Am2013-2595 |
0.35 |
|
| 2012 |
Imperiale TF, Glowinski EA, Lin-Cooper C, Ransohoff DF. Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia. The American Journal of Medicine. 125: 1181-7. PMID 23062404 DOI: 10.1016/j.amjmed.2012.05.026 |
0.367 |
|
| 2012 |
Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Annals of Internal Medicine. 156: 703-9. PMID 22586009 DOI: 10.7326/0003-4819-156-10-201205150-00006 |
0.315 |
|
| 2012 |
Zapka J, Klabunde CN, Taplin S, Yuan G, Ransohoff D, Kobrin S. Screening colonoscopy in the US: attitudes and practices of primary care physicians. Journal of General Internal Medicine. 27: 1150-8. PMID 22539065 DOI: 10.1007/s11606-012-2051-3 |
0.319 |
|
| 2011 |
Brawley O, Byers T, Chen A, Pignone M, Ransohoff D, Schenk M, Smith R, Sox H, Thorson AG, Wender R. New American Cancer Society process for creating trustworthy cancer screening guidelines. Jama. 306: 2495-9. PMID 22166609 DOI: 10.1001/Jama.2011.1800 |
0.588 |
|
| 2011 |
Ransohoff DF, Pignone M, Russell LB. Using models to make policy: an inflection point? Medical Decision Making : An International Journal of the Society For Medical Decision Making. 31: 527-9. PMID 21757648 DOI: 10.1177/0272989X11412079 |
0.448 |
|
| 2011 |
Pignone M, Ransohoff DF. Cross-model comparisons to improve the value of modeling: the case of colorectal cancer screening. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 31: 524-6. PMID 21757647 DOI: 10.1177/0272989X11412195 |
0.522 |
|
| 2011 |
Ransohoff DF, Yankaskas B, Gizlice Z, Gangarosa L. Recommendations for post-polypectomy surveillance in community practice. Digestive Diseases and Sciences. 56: 2623-30. PMID 21698368 DOI: 10.1007/s10620-011-1791-y |
0.301 |
|
| 2011 |
Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, ... ... Ransohoff D, et al. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. European Journal of Clinical Investigation. 41: 1010-35. PMID 21434890 DOI: 10.1111/J.1365-2362.2011.02493.X |
0.345 |
|
| 2011 |
Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, ... ... Ransohoff D, et al. Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. Journal of Clinical Epidemiology. 64: e1-e22. PMID 21414753 DOI: 10.1016/J.Jclinepi.2011.02.003 |
0.344 |
|
| 2011 |
Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, ... ... Ransohoff D, et al. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. European Journal of Human Genetics : Ejhg. 19: 18 p preceding 494. PMID 21407270 DOI: 10.1038/Ejhg.2011.27 |
0.343 |
|
| 2010 |
Doria-Rose VP, Vinden C, Ransohoff DF, Prorok PC. Flexible sigmoidoscopy to prevent colorectal cancer. Lancet (London, England). 376: 871; author reply 87. PMID 20833296 DOI: 10.1016/S0140-6736(10)61407-9 |
0.331 |
|
| 2010 |
Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Seminars in Oncology. 37: 202-15. PMID 20709205 DOI: 10.1053/j.seminoncol.2010.05.006 |
0.348 |
|
| 2010 |
Ransohoff DF. Can endoscopy protect against colorectal cancer? An RCT. Lancet (London, England). 375: 1582-4. PMID 20430430 DOI: 10.1016/S0140-6736(10)60626-5 |
0.323 |
|
| 2010 |
Imperiale TF, Ransohoff DF. Understanding differences in the guidelines for colorectal cancer screening. Gastroenterology. 138: 1642-1647.e1. PMID 20302867 DOI: 10.1053/j.gastro.2010.03.027 |
0.397 |
|
| 2009 |
Imperiale T, Glowinski E, Lin-Cooper C, Ransohoff D. Validation of a Risk Index for Advanced Proximal Colorectal Neoplasia in Asymptomatic Adults: 1481 The American Journal of Gastroenterology. 104. DOI: 10.14309/00000434-200910003-01481 |
0.338 |
|
| 2008 |
Zauber AG, Levin TR, Jaffe CC, Galen BA, Ransohoff DF, Brown ML. Implications of new colorectal cancer screening technologies for primary care practice. Medical Care. 46: S138-46. PMID 18725826 DOI: 10.1097/MLR.0b013e31818192ef |
0.331 |
|
| 2008 |
Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF. Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 799-804. PMID 18381471 DOI: 10.1158/1055-9965.Epi-07-2620 |
0.466 |
|
| 2008 |
Imperiale T, Ransohoff D. Risk of Colorectal Cancer (CRC) in Persons with a Family History (Fhx) of Adenomatous Polyps: a Systematic Review The American Journal of Gastroenterology. 103. DOI: 10.14309/00000434-200809001-01412 |
0.388 |
|
| 2007 |
Welch HG, Woloshin S, Schwartz LM, Gordis L, Gøtzsche PC, Harris R, Kramer BS, Ransohoff DF. Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study. Archives of Internal Medicine. 167: 2289-95. PMID 18039986 DOI: 10.1001/Archinte.167.21.2289 |
0.343 |
|
| 2007 |
Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF. Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2118-27. PMID 17932360 DOI: 10.1158/1055-9965.Epi-07-0123 |
0.498 |
|
| 2007 |
Ransohoff DF. What is the role of iFOBT in screening for colorectal cancer? Gut. 56: 1343-4. PMID 17872566 DOI: 10.1136/gut.2007.124107 |
0.375 |
|
| 2007 |
Klabunde CN, Lanier D, Breslau ES, Zapka JG, Fletcher RH, Ransohoff DF, Winawer SJ. Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. Journal of General Internal Medicine. 22: 1195-205. PMID 17534688 DOI: 10.1007/s11606-007-0231-3 |
0.371 |
|
| 2007 |
Lieberman D, Nadel M, Smith RA, Atkin W, Duggirala SB, Fletcher R, Glick SN, Johnson CD, Levin TR, Pope JB, Potter MB, Ransohoff D, Rex D, Schoen R, Schroy P, et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointestinal Endoscopy. 65: 757-66. PMID 17466195 DOI: 10.1016/j.gie.2006.12.055 |
0.314 |
|
| 2006 |
Meyskens FL, Ransohoff DF. Predicting risk for the appearance of melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3522-3. PMID 16728487 DOI: 10.1200/Jco.2006.06.8163 |
0.307 |
|
| 2005 |
Ransohoff DF. Colon cancer screening in 2005: status and challenges. Gastroenterology. 128: 1685-95. PMID 15887159 DOI: 10.1053/j.gastro.2005.04.005 |
0.373 |
|
| 2005 |
Lipkus IM, Skinner CS, Dement J, Pompeii L, Moser B, Samsa GP, Ransohoff D. Increasing colorectal cancer screening among individuals in the carpentry trade: test of risk communication interventions. Preventive Medicine. 40: 489-501. PMID 15749130 DOI: 10.1016/J.Ypmed.2004.09.019 |
0.371 |
|
| 2005 |
Ransohoff DF. Lessons from controversy: ovarian cancer screening and serum proteomics. Journal of the National Cancer Institute. 97: 315-9. PMID 15713968 DOI: 10.1093/jnci/dji054 |
0.344 |
|
| 2005 |
Patnick J, Ransohoff D, Atkin W, Borras JM, Elwood M, Hoff G, Nadel M, Russo A, Simon J, Weiderpass E, Weiderpass-Vaino E, Zappa M, Smith R. Workgroup III: facilitating screening for colorectal cancer: quality assurance and evaluation. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Annals of Oncology : Official Journal of the European Society For Medical Oncology. 16: 34-7. PMID 15598934 DOI: 10.1093/Annonc/Mdi032 |
0.478 |
|
| 2005 |
Patnick J, Ransohoff D, Atkin W, Borras JM, Elwood M, Hoff G, Nadel M, Russo A, Simon J, Weiderpass EV, Zappa M, Smith R. Erratum: Workgroup III: Facilitating screening for colorectal cancer: Quality assurance and evaluation. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002) (Annals of Oncology (2005) vol. 16 (34-37)) Annals of Oncology. 16. DOI: 10.1093/Annonc/Mdi197 |
0.479 |
|
| 2004 |
Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. The New England Journal of Medicine. 351: 2704-14. PMID 15616205 DOI: 10.1056/NEJMoa033403 |
0.318 |
|
| 2004 |
van Dam J, Cotton P, Johnson CD, McFarland BG, Pineau BC, Provenzale D, Ransohoff D, Rex D, Rockey D, Wootton FT. AGA future trends report: CT colonography. Gastroenterology. 127: 970-84. PMID 15362051 DOI: 10.1053/J.Gastro.2004.07.003 |
0.381 |
|
| 2004 |
Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Annals of Internal Medicine. 141: 264-71. PMID 15313742 DOI: 10.7326/0003-4819-141-4-200408170-00006 |
0.364 |
|
| 2003 |
Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Using Risk for Advanced Proximal Colonic Neoplasia to Tailor Endoscopic Screening for Colorectal Cancer Annals of Internal Medicine. 139: 959-965+I10. PMID 14678915 |
0.368 |
|
| 2003 |
Lipkus IM, Samsa GP, Dement J, Skinner CS, Green LS, Pompeii L, Ransohoff DF. Accuracy of self-reports of fecal occult blood tests and test results among individuals in the carpentry trade. Preventive Medicine. 37: 513-9. PMID 14572436 DOI: 10.1016/S0091-7435(03)00178-6 |
0.315 |
|
| 2003 |
Ransohoff DF. Screening colonoscopy in balance. Issues of implementation. Gastroenterology Clinics of North America. 31: 1031-44, vii. PMID 12489276 DOI: 10.1016/s0889-8553(02)00059-6 |
0.378 |
|
| 2002 |
Shaheen N, Ransohoff DF. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. Jama. 287: 1972-81. PMID 11960540 DOI: 10.1001/jama.287.15.1972 |
0.311 |
|
| 2002 |
Ransohoff DF, Sandler RS. Clinical practice. Screening for colorectal cancer. The New England Journal of Medicine. 346: 40-4. PMID 11778002 DOI: 10.1056/Nejmcp010886 |
0.399 |
|
| Show low-probability matches. |